Dr. Tobias Peikert

About Dr. Tobias Peikert

Tobias Peikert is a board-certified physician at Mayo Clinic in Rochester, Minnesota, who treats patients with mesothelioma and other complex diseases.

At Mayo Clinic, Dr. Peikert works alongside medical oncologists, thoracic surgeons, and radiation oncologists to provide coordinated care that can help patients live longer and more comfortably.

He’s also actively involved in cancer research, particularly in studying how the immune system interacts with mesothelioma tumors. His work helps guide newer treatment approaches and expand options for patients affected by asbestos exposure.

Patients diagnosed with mesothelioma frequently have questions about treatment decisions, prognosis, and clinical trials. Working with an experienced mesothelioma specialist can help patients better understand the next steps after diagnosis.

Use our Free Doctor Match to connect with Dr. Tobias Peikert and learn more about treatment options available at Mayo Clinic.

What Health Conditions Does Dr. Tobias Peikert Treat?

Dr. Peikert focuses on diseases affecting the lungs and chest, particularly those linked to asbestos exposure.

He’s able to treat patients suffering from:

• Pleural mesothelioma: A rare cancer affecting the pleura
• Lung cancer: Including non-small cell lung cancer
• Pulmonary disease: Complex respiratory conditions requiring specialized care

He works closely with other specialists to ensure mesothelioma patients receive coordinated and comprehensive care.

Dr. Tobias Peikert’s Mesothelioma Treatment Approach

Dr. Tobias Peikert takes a research-driven approach to mesothelioma treatment, focusing on improving outcomes through innovation and personalized care.

Dr. Peikert specializes in treatments like:

• Chemotherapy: Using cancer-fighting drugs to slow mesothelioma tumor growth and help manage symptoms
• Immunotherapy: Administering medications to help the immune system attack cancer cells more effectively
• Targeted therapy: Matching treatments to the unique characteristics of a patient’s tumor
• Clinical trials: Enrolling eligible patients in studies testing new treatments and emerging therapies

He evaluates each patient’s diagnosis, biopsy results, and disease progression to guide treatment planning. His work also focuses on reducing side effects while improving long-term outcomes.

Download our Free Checklist of Questions to Ask Your Doctor to help prepare for treatment conversations with Dr. Peikert and other mesothelioma specialists.

Dr. Tobias Peikert’s Medical Background

Dr. Tobias Peikert earned his medical degree from Martin Luther University Halle-Wittenberg in Germany. He then moved to the United States and completed his internal medicine residency at Cleveland Clinic Foundation in Ohio.

After residency, Dr. Peikert completed postdoctoral research training in cancer biology at Cleveland Clinic. He later trained at Mayo Clinic College of Medicine and Science in Rochester, Minnesota, where he completed a fellowship in pulmonary disease and critical care medicine.

His training in pulmonary medicine, critical care, and cancer research supports his work treating patients with mesothelioma and lung cancer.

Work Experience

Dr. Peikert has built his career at one of the nation’s leading medical centers.

His experience includes:

• Pulmonologist and specialist at Mayo Clinic in Rochester, Minnesota
• Clinical roles in pulmonary medicine and critical care medicine
• Active involvement in thoracic oncology programs
• Participation in national and international cancer research collaborations

His work spans both clinical care and research, helping bring new treatments to mesothelioma patients.

Highlights of Dr. Tobias Peikert’s Medical Career

Dr. Tobias Peikert is known for his work in mesothelioma research, immunotherapy, and clinical trials. His research focuses on improving treatment options and identifying which patients may benefit most from newer therapies.

Awards and Accolades

Dr. Peikert has received recognition for his clinical work and contributions to health care.

His awards and honors include:

• Annenberg Career Development Award
• Eagles Cancer Fellowship Award
• V Foundation Scholar Award

Professional Affiliations

Dr. Peikert is involved in several professional organizations and collaborative research groups focused on pulmonary medicine, oncology, and mesothelioma treatment.

His professional affiliations and research collaborations include:

• International Association for the Study of Lung Cancer (IASLC)
• Mesothelioma Applied Research Foundation
• National Cancer Institute (NCI)

Through these affiliations, Dr. Peikert contributes to ongoing research efforts aimed at improving mesothelioma treatment, expanding clinical trial access, and advancing personalized cancer care.

Dr. Peikert’s Work in Cancer Treatment & Clinical Trials

Dr. Peikert is involved in clinical trials focused on finding better treatment options for people with mesothelioma. His research looks at new ways to slow cancer growth, improve symptoms, and help patients live longer.

His work includes:

• Studying immunotherapy drugs called immune checkpoint inhibitors, which help the body’s immune system recognize and attack cancer cells
• Researching targeted therapies designed for tumors with specific genetic changes or mutations
• Exploring cell therapy and other emerging treatments that may offer new options when standard treatments are no longer working
• Working with national cancer research groups to help develop and test new mesothelioma treatments in clinical trials

Through this work, Dr. Peikert helps patients gain access to promising therapies that may not be widely available outside of clinical trials. He also helps patients understand whether a trial may be a good fit for their diagnosis, treatment history, and overall health.

Dr. Tobias Peikert’s Mesothelioma Research and Published Works

Dr. Peikert has contributed to significant research in mesothelioma and thoracic oncology.

Some of his published works include:

• The Role of microRNAs and Competing Endogenous RNA Regulatory Networks in Mesothelioma Response to Immunotherapy. Published in Lung Cancer, July 2026.
• Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma. Published in JTO Clinical Research Reports, March 2024.
• Dynamics and Survival Associations of T Cell Receptor Clusters in Patients With Pleural Mesothelioma Treated With Immunotherapy. Published in Journal for ImmunoTherapy of Cancer (JITC), June 2023.
• Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors. Published in Journal of Thoracic Oncology, February 2022.

His research also includes experimental approaches such as modified measles virus therapy, which is being studied as a way to help the immune system target mesothelioma tumors more effectively.

“Cancers in general… have figured out a way to avoid and suppress our immune response against them.”
– Dr. Tobias Peikert, mesothelioma specialist

Get Connected With Dr. Tobias Peikert for Mesothelioma Treatment

A mesothelioma diagnosis can leave patients and families with difficult questions about treatment, prognosis, and where to turn for specialized care. Working with an experienced mesothelioma specialist can help patients better understand their options and feel more supported throughout treatment.

Dr. Tobias Peikert is known for combining pulmonary expertise with research-driven cancer care. He helps mesothelioma patients at Mayo Clinic explore personalized treatment plans that may include chemotherapy, radiation therapy, immunotherapy, thoracic surgery, and clinical trial opportunities.

At Mesothelioma Hope, we help connect patients and families with experienced mesothelioma doctors, leading cancer centers, and support resources.

If you or a loved one has been diagnosed with mesothelioma, our Patient Advocates are here to help. Call (866) 608-8933 or use our Free Doctor Match to learn more about connecting with Dr. Peikert and exploring available treatment options.